These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35046826)

  • 1. Human Arylamine
    Carlisle SM; Trainor PJ; Doll MA; Hein DW
    Front Pharmacol; 2021; 12():803254. PubMed ID: 35046826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9 knockout of human arylamine N-acetyltransferase 1 in MDA-MB-231 breast cancer cells suggests a role in cellular metabolism.
    Carlisle SM; Trainor PJ; Hong KU; Doll MA; Hein DW
    Sci Rep; 2020 Jun; 10(1):9804. PubMed ID: 32555504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockout of human arylamine N-acetyltransferase 1 (NAT1) in MDA-MB-231 breast cancer cells leads to increased reserve capacity, maximum mitochondrial capacity, and glycolytic reserve capacity.
    Carlisle SM; Trainor PJ; Doll MA; Stepp MW; Klinge CM; Hein DW
    Mol Carcinog; 2018 Nov; 57(11):1458-1466. PubMed ID: 29964355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and small molecule inhibition of arylamine N-acetyltransferase 1 reduces anchorage-independent growth in human breast cancer cell line MDA-MB-231.
    Stepp MW; Doll MA; Carlisle SM; States JC; Hein DW
    Mol Carcinog; 2018 Apr; 57(4):549-558. PubMed ID: 29315819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
    Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
    Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
    Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human
    Hein DW; Doll MA; Habil MR
    Front Pharmacol; 2022; 13():821133. PubMed ID: 35281898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untargeted polar metabolomics of transformed MDA-MB-231 breast cancer cells expressing varying levels of human arylamine
    Carlisle SM; Trainor PJ; Yin X; Doll MA; Stepp MW; States JC; Zhang X; Hein DW
    Metabolomics; 2016 Jul; 12(7):. PubMed ID: 27872580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rat arylamine N-acetyltransferases 1 and 2.
    Walraven JM; Doll MA; Hein DW
    J Pharmacol Exp Ther; 2006 Oct; 319(1):369-75. PubMed ID: 16829624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): acetylator genotype-dependent N- and O-acetylation of arylamine carcinogens.
    Hein DW; Doll MA; Rustan TD; Gray K; Ferguson RJ; Feng Y
    Toxicol Appl Pharmacol; 1994 Jan; 124(1):16-24. PubMed ID: 8291057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of arylamine N-acetyltransferase 1 in MDA-MB-231 human breast cancer cells reduces primary and secondary tumor growth in vivo with no significant effects on metastasis.
    Doll MA; Ray AR; Salazar-González RA; Shah PP; Vega AA; Sears SM; Krueger AM; Hong KU; Beverly LJ; Hein DW
    Mol Carcinog; 2022 May; 61(5):481-493. PubMed ID: 35133049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of human arylamine N-acetyltransferase I knockdown in triple-negative breast cancer cell lines.
    Tiang JM; Butcher NJ; Minchin RF
    Cancer Med; 2015 Apr; 4(4):565-74. PubMed ID: 25627111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental expression of arylamine N-acetyltransferases: evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2.
    Smelt VA; Mardon HJ; Sim E
    Pharmacol Toxicol; 1998 Oct; 83(4):149-57. PubMed ID: 9820875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arylamine
    Salazar-González RA; Doll MA; Hein DW
    Front Pharmacol; 2022; 13():797469. PubMed ID: 35153780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice.
    Sugamori KS; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
    Mol Pharmacol; 2003 Jul; 64(1):170-9. PubMed ID: 12815173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding.
    Laurieri N; Kawamura A; Westwood IM; Varney A; Morris E; Russell AJ; Stanley LA; Sim E
    BMC Pharmacol Toxicol; 2014 Nov; 15():68. PubMed ID: 25432241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
    Grant DM; Blum M; Beer M; Meyer UA
    Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable Isotope Tracing Reveals an Altered Fate of Glucose in
    Wise JTF; Yin X; Ma X; Zhang X; Hein DW
    Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of estrogen receptor 1 and N‑acetyltransferase gene expression in normal breast tissue, primary breast tumors, and established breast cancer cell lines.
    Carlisle SM; Hein DW
    Int J Oncol; 2018 Aug; 53(2):694-702. PubMed ID: 29901116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2.
    Liu L; Von Vett A; Zhang N; Walters KJ; Wagner CR; Hanna PE
    Chem Res Toxicol; 2007 Sep; 20(9):1300-8. PubMed ID: 17672512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.